Skin test conversion following transfer factor. A double-blinded study of normal individuals
- PMID: 340492
- DOI: 10.1016/0091-6749(78)90234-8
Skin test conversion following transfer factor. A double-blinded study of normal individuals
Abstract
The use of skin test conversion as a measure of change in cellular immune status is a fairly routine procedure despite considerable potential for variation in testing. This study is a double-blinded and randomized reassessment of this assay in the context of transfer factor (TF) activity. Thirty-three normal people with negative tuberculin skin tests received either dialyzable TF, column purified TF, hypoxanthine, or saline in a randomized and double-blinded fashion. Skin test reactivity to tuberculin and keyhole limpet hemocyanin (KLH) was read by three of the investigators. Nine of 20 recipients of TF and 7 of 13 controls demonstrated an increase in tuberculin reactivity after "transfer." Four reactions were greater than 10 mm. Fourteen of 20 recipients of TF and 7 of 13 controls demonstrated some reactivity to KLH on initial testing post-transfer. Control solutions were as effective as TF preparations in "causing" skin test conversion. These observations stress the importance of controlled and and blinded studies when serial skin test reactivity is used to evaluate cellular immune status in humans.
Similar articles
-
Adoptive transfer of delayed wattle reactivity in chickens with a dialyzable leukocyte extract containing transfer factor.Poult Sci. 1983 May;62(5):767-71. doi: 10.3382/ps.0620767. Poult Sci. 1983. PMID: 6878121
-
Immunologic specificity of transfer factor.J Clin Invest. 1974 Oct;54(4):997-1000. doi: 10.1172/JCI107841. J Clin Invest. 1974. PMID: 4139171 Free PMC article.
-
Dialysable leukocyte extracts (transfer factor) augment nonspecifically keyhole limpet haemocyanin and horseshoe crab haemocyanin skin reactivity in unimmunized human recipients.Scand J Immunol. 1986 Feb;23(2):161-7. doi: 10.1111/j.1365-3083.1986.tb01954.x. Scand J Immunol. 1986. PMID: 3952468
-
Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.Immunology. 1979 Jan;36(1):1-12. Immunology. 1979. PMID: 369991 Free PMC article. Clinical Trial.
-
Indications, usage, and dosage of the transfer factor.Rev Alerg Mex. 2007 Jul-Aug;54(4):134-9. Rev Alerg Mex. 2007. PMID: 18297853 Review.
Cited by
-
Transfer factor therapy in hyperimmunoglobulinaemia E syndrome.Clin Exp Immunol. 1979 Jun;36(3):465-72. Clin Exp Immunol. 1979. PMID: 487648 Free PMC article.
-
Transfer factor: failure to transfer reactivity in normal human subjects.Clin Exp Immunol. 1980 Mar;39(3):708-16. Clin Exp Immunol. 1980. PMID: 7379334 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous